RaySearch Laboratories Reports Record Q3 2026 Sales

RaySearch Laboratories reported record Q3 2026 sales of SEK 394 million, up 19% year over year, while order intake increased 30%, driven largely by strong U.S. demand. A shift in hardware mix and higher operating costs pressured profit margins. Management reaffirmed its full-year 2026 target of an operating margin of at least 25%. No stock-price movement was reported.